FDA approved Cervarix, GlaxoSmithKline’s cervical cancer vaccine
On Oct. 16, 2009, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Cervarix [Human papillomavirus…
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
HHS announced advanced development contract for new way to make flu vaccine
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
Biotechnology | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Vaccine
OHSU, University of Washington scientists partner to form regional center aimed at combating infectious diseases
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
ACIP voted to recommend hepatitis A vaccination for close contacts of international adoptees
On Feb. 25, 2009, the Advisory Committee on Immunization Practices (ACIP) recommended routine hepatitis A vaccination for household…
Vaccine Court ruled that MMR vaccine does not cause autism
On Feb. 12, 2009, the Vaccine Court ruled that MMR vaccine, when administered with thimerosal-containing vaccines, does not…
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
An increased risk of narcolepsy was found following vaccination with Pandemrix
In 2009, an increased risk of narcolepsy (a chronic sleep disorder) was found following vaccination with Pandemrix, a…
Drs. Judith James and Linda Thompson at the OMRF helped develop a H1N1 or ‘swine flu’ vaccine
In 2009, Drs. Judith James and Linda Thompson at the Oklahoma Medical Research Foundation (OMRF) helped develop an…
FDA approved changes in the schedule for administering anthrax vaccine
On Dec. 19, 2008, the Food and Drug Administration (FDA) approved changes in the schedule for administering anthrax…
FDA approved expanded indication for use of Boostrix Tdap vaccine in people ages 10-64 years
On Dec. 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus…
Biotechnology | FDA | Life Science News | Polio | Vaccine
FDA approved new DTaP-IPV vaccine (Kinrix) for use in children ages 4-6 years
On Jun. 24, 2008, the U.S. Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoid…
Biotechnology | FDA | Life Science News | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration had licensed Pentacel, Diphtheria and…
FDA approved the use of Sanofi Pasteur’s Tenivac tetanus and diphtheria toxoids
On Jun. 5, 2008, the FDA approved the use of Sanofi Pasteur’s Tenivac tetanus and diphtheria toxoids adsorbed…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | Vaccine
World Malaria Day established by the United Nations
On Apr. 25, 2008, marked the first-ever World Malaria Day established by the United Nations to ensure that…
FDA approved new rotavirus vaccine for use in U.S.
On Apr. 3, 2008, the U.S. Food and Drug Administration (FDA) approved new rotavirus vaccine (Rotarix) for use…
CDC | Life Science News | Measles | Vaccine
CDC updated its recommendations for administering combination MMRV vaccine
On Mar. 14, 2008, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendations for administering…
ACIP voted to expand influenza recommendation to include vaccination for children ages 6 months-18 years
On Feb. 27, 2008, the Immunization Practices Advisory Committee (Immunization Practices Advisory Committee (ACIP) voted to expand influenza…
The Vaccine & Gene Therapy Institute of Florida was founded
In 2008, the Vaccine & Gene Therapy Institute of Florida VGTI Florida (VGTI-FL) was founded as an independent…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Life Science News | Pharmaceutical | Vaccine
Merck voluntarily recalled 12 million doses of Haemophilus influenzae type b
On Dec. 12, 2007, Merck voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines due…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Plague | Vaccine
The One Health approach was recommended for pandemic preparedness
On Dec. 4, 2007, representatives of 111 countries and 29 international organizations met in New Delhi India for…
ACIP voted to recommend the use of FluMist
On Oct. 26, 2007, the Immunization Practices Advisory Committee (ACIP) voted to recommend the use of FluMist, the…
CDC published updated recommendations for prevention of hepatitis A virus infection
On Oct. 19, 2007, the U.S. Centers for Disease Control and Prevention (CDC) published updated recommendations for prevention…
CDC published updated recommendation for meningococcal vaccination of at-risk children age 2-10 years in MMWR
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
The CDC revised recommendations to vaccinate all persons ages 11-18 with MCV4 at earliest opportunity
On Aug 10, 2007, the U.S. Centers for Disease Control and Prevention (CDC) notified MMWR readers of revised…
HHS announced $175 million to assist states in pandemic influenza preparedness efforts
On Jul. 17, 2007, The US Department of Health and Human Services (HHS) announced it was providing states,…
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…